Benzinga's Microcap Movers for Wednesday November 7, 2012
Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:
Shares of Medical Marijuana (OTC: MJNA), the San Diego, CA medical marijuana and industrial hemp company, rose 22.04% Wednesday on 5 times average volume.
Medical Marijuana was boosted by the Colorado voters passage of Amendment 64 amd Washington state voters passage of Initiative 502 legalizing marijuana for recreational use. In addition, Massachusetts voters approved medical marijuana use for certain conditions.
Medical Marijuana closed at $0.14 on Wednesday.
Shares of Amyris (NASDAQ: AMRS), the Emeryville, CA renewable products company, rose 4.25% Wednesday on 6 times average volume.
Amyris reported a narrower than expected loss Tuesday of $0.34 per share vs. $0.97 a year ago.
Amyris closed at $2.70 on Wednesday.
China Auto Logistics
Shares of China Auto Logistics (NASDAQ: CALI), the China-based seller of imported luxury vehicles, rose 82.93% Wednesday on 57 times average volume.
China Auto Logistics announced Wednesday receipt of a letter from The NASDAQ Stock Market notifying the Company that it has regained compliance with NASDAQ's minimum bid price continued listing requirement, as a result of the closing bid price of its common stock having been at or above the minimum requirement of $1.00 per share for at least 10 consecutive trading days.
China Auto Logistics closed at $2.25 on Wednesday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.